Literature DB >> 23493024

Workload and time management in central cancer registries: baseline data and implication for registry staffing.

Susan A Chapman, Linda Mulvihill, Carolina Herrera.   

Abstract

The Workload and Time Management Survey of Central Cancer Registries was conducted in 2011 to assess the amount of time spent on work activities usually performed by cancer registrars. A survey including 39 multi-item questions,together with a work activities data collection log, was sent by email to the central cancer registry (CCR) manager in each of the 50 states and the District of Columbia. Twenty-four central cancer registries (47%) responded to the survey.Results indicate that registries faced reductions in budgeted staffing from 2008-2009. The number of source records and total cases were important indicators of workload. Four core activities, including abstracting at the registry, visual editing,case consolidation, and resolving edit reports, accounted for about half of registry workload. We estimate an average of 12.4 full-time equivalents (FTEs) are required to perform all cancer registration activities tracked by the survey; however,estimates vary widely by registry size. These findings may be useful for registries as a benchmark for their own registry workload and time-management data and to develop staffing guidelines.

Entities:  

Mesh:

Year:  2012        PMID: 23493024      PMCID: PMC4487809     

Source DB:  PubMed          Journal:  J Registry Manag        ISSN: 1945-6131


  2 in total

1.  The past, present, and future of cancer incidence in the United States: 1975 through 2020.

Authors:  Hannah K Weir; Trevor D Thompson; Ashwini Soman; Bjørn Møller; Steven Leadbetter
Journal:  Cancer       Date:  2015-02-03       Impact factor: 6.860

2.  Population Heath Informatics Can Advance Interoperability: National Program of Cancer Registries Electronic Pathology Reporting Project.

Authors:  Lori A Pollack; Sandra F Jones; Wendy Blumenthal; Temitope O Alimi; David E Jones; Joseph D Rogers; Vicki B Benard; Lisa C Richardson
Journal:  JCO Clin Cancer Inform       Date:  2020-10
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.